Document is current
Any future updates will be listed below
-
Authors
Fischer, Jörg
Wenninger, Ralf
Löffelad, Lena
Volc, Sebastian
-
Funding
Funding for this research was provided by:
Universität Augsburg
- License Information
-
More Information
Article History
Received: 25 September 2025
Accepted: 10 October 2025
First Online: 4 December 2025
Conflict of interest
: J. Fischer received lecture fees from ALK-Abelló, Bencard, Bristol Myers Squibb, Novartis, Janssen-Cilag, Sanofi-Aventis, AeDA (Association of German Allergologists), and GEKA (Society for Experimental and Clinical Respiratory Research), consulting fees from Bencard and Sanofi-Aventis, and travel grants from Pierre Fabre Oncology outside the scope of the submitted paper. He is a member of the AeDA and the DGAKI (German Society for Allergology and Clinical Immunology) and is deputy spokesperson for the DGAKI’s Working Group on Insect Venom Allergy. S. Volc received consulting fees from AbbVie, Almirall Hermal, Amgen, Leo Pharma, Novartis, and Pfizer, as well as support for conference attendance and/or travel from AbbVie, Amgen, Almirall Hermal, and Pfizer. In addition, he received payments or fees for lectures and presentations from Almirall Hermal, Leo Pharma, Novartis, and Pfizer. R. Wenninger and L. Löffelad declare that they have no competing interests.
